No abstract available
MeSH terms
-
Animals
-
Autoantigens / immunology*
-
Child
-
Clinical Trials, Phase III as Topic
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 1 / immunology
-
Disease Progression
-
Europe
-
Financial Support
-
Glutamate Decarboxylase / immunology*
-
Humans
-
Treatment Outcome
-
Vaccination
Substances
-
Autoantigens
-
Glutamate Decarboxylase
-
glutamate decarboxylase 2